3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods
Three-dimensional quantitative structure–activity relationship (3D-QSAR) modelling was conducted on a series of leucine-rich repeat kinase 2 (LRRK2) antagonists using CoMFA and CoMSIA methods.
Pourbasheer, E., Aalizadeh, R.
core +1 more source
Fernando D. González-Nilo. Centro de Bioinformática y Simulación Molecular, Universidad de Talca, 2 Norte 685, Casilla 721, Talca, Chile.Three-dimensional quantitative structure–activity relationship (3D-QSAR) studies were carried out on a series of 38 ...
González-Nilo, F. +3 more
core
In Silico Development of Novel Quinazoline-Based EGFR Inhibitors via 3D-QSAR, Docking, ADMET, and Molecular Dynamics. [PDF]
Moussaoui M +10 more
europepmc +1 more source
Discovery of New 7-Propanamide Benzoxaborole as Potent Anti-SKOV3 Agent via 3D-QSAR Models. [PDF]
Ji L, Zhang J, Zhou H, Zhao Y.
europepmc +1 more source
Integration of machine learning in 3D-QSAR CoMSIA models for the identification of lipid antioxidant peptides. [PDF]
Nha Tran TT, Thuan Tran TD, Thuy Bui TT.
europepmc +1 more source
Based on 3D-QSAR modeling and molecular dynamics of novel peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 inhibitors design and screening. [PDF]
Xu D, Li J, Li Y, Dou J.
europepmc +1 more source
Targeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia. [PDF]
Lin J +5 more
europepmc +1 more source
Developing a CoMSIA Model for Inhibition of COX-2 by Resveratrol Derivatives.
Design of selective cyclooxygenase-2 (COX-2) inhibitors is still a challenging task because of active site similarities between COX isoenzymes. To help with this issue, we tried to generate a 3D-QSAR (3 dimensional quantitative structure activity relationships) model that might reflect the essential features of COX-2 active sites. Compounds in a series
Jamal, Shamsara, Ahmad, Shahir-Sadr
openaire +1 more source
Discovery of novel angiotensin-converting enzyme inhibitory peptides by <i>in silico</i> and <i>in vitro</i> studies. [PDF]
Jiao F, Yang J, Wang F, Peng S, Zhou B.
europepmc +1 more source
Current Computational Approaches for the Discovery of Novel Anticancer Agents Targeting VEGFR and SIRT Signaling Pathways. [PDF]
Ilic A +5 more
europepmc +1 more source

